1-3 of 3
Yasuhiro Sugio
Close
Sort by
Journal Articles

CHOP Plus Sequential Mogamulizumab As First-Line Therapy for Untreated Adult T-Cell Leukemia-Lymphoma

Kazuki Tanimoto, Koji Kato, Takatoshi Aoki, Goichi Yoshimoto, Ilseung Choi, Masanori Kadowaki, Yasuhiro Sugio, Takuro Kuriyama, Noriaki Kawano, Ritsuro Suzuki, Kohta Miyawaki, Hideho Henzan, Noriyuki Saito, Takanori Ohta, Toshihiro Miyamoto, Koichi Akashi
Journal: Blood
Blood (2021) 138 (Supplement 1): 1393.
https://doi.org/10.1182/blood-2021-151937
Published: 2021
Journal Articles

Individually Tailored Treatment Strategies For Frail Myeloma Patients In Japan

Ryosuke Ogawa, MD, PhD, Takanori Ohta, MD, Kenichi Aoki, MD, Hirotake Kusumoto, MD, Mariko Minami, MD, Masakazu Higuchi, MD, PhD, Yasuhiro Sugio, MD, Yuju Ohno, MD
Journal: Blood
Blood (2013) 122 (21): 5614.
https://doi.org/10.1182/blood.V122.21.5614.5614
Published: 2013
Journal Articles

Unfavorable Outcome of Single-Unit Umbilical Cord Blood Transplantation for Elderly Patients with Myelodysplastic Syndromes.

Kazunari Aoki, MD, Ken Ishiyama, MD, PhD, Hidehiro Itonaga, MD, Takahiro Fukuda, MD, PhD, Shuichi Taniguchi, MD, PhD, Yasunori Ueda, MD, PhD, Noriko Doki, MD, Yasuhiro Sugio, MD, Yasuo Morishima, MD, Tokiko Nagamura, MD, PhD, Junji Tanaka, M.D., Yoshiko Atsuta, MD, PhD, Takayuki Ishikawa, M.D., Ph.D., Yasushi Miyazaki, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3118.
https://doi.org/10.1182/blood.V120.21.3118.3118
Published: 2012